<DOC>
	<DOC>NCT01212432</DOC>
	<brief_summary>Daptomycin kinetics in CRRT - Trial with medicinal product</brief_summary>
	<brief_title>Daptomycin Pharmacokinetics in Critically Ill Patients Undergoing Continuous Veno-venous Hemodiafiltration, a Dose Finding Study</brief_title>
	<detailed_description />
	<mesh_term>Bacterial Infections</mesh_term>
	<mesh_term>Gram-Positive Bacterial Infections</mesh_term>
	<mesh_term>Daptomycin</mesh_term>
	<criteria>Inclusion criteria: male or female of 18 years or older females: negative pregnancy test Hospitalisation in the medical ICU High suspicion or evidence of Grampositive infections requiring antibiotic therapy Subjects receiving standard antibiotic treatment for Grampositive infection Evidence of renal failure Clinical necessity for continuous renal replacement therapy Written informed consent signed by the patient or a next of kin and an independent physician in case the patient is not able to sign. Exclusion criteria: Skeletal muscle disorders or CPK levels of &gt; 2 x ULN History of hypersensitivity to the drug Participation in another study Subjects with a history of muscle disease Patients with severe liver function impairment (Child Life expectancy of less than 5 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Gram positive infection and CRRT</keyword>
</DOC>